HARP Project

The HARP Project, or HPV in Africa Research Partnership, represents a significant international collaboration focused on understanding and addressing cervical cancer in African contexts. By bringing together research institutions across multiple countries, the partnership aims to examine how HPV affects different populations, with particular attention to women’s health. The project recognizes that cervical cancer prevention requires coordinated efforts spanning screening programmes, treatment access, and community engagement, especially in regions where healthcare infrastructure may be limited and where the burden of disease intersects with broader reproductive health challenges across diverse settings and population groups throughout the African continent and connected regions today.

At the heart of the project’s mission lies a commitment to evaluating both the effectiveness and the broader impact of various prevention strategies. Researchers associated with the consortium investigate how screening programmes can be adapted to local realities, how treatment pathways might be strengthened, and how public health interventions can reach the women who need them most. The partnership draws on expertise from universities, tropical medicine and hygiene institutions, and reproductive health units, creating a collaborative framework that combines scientific rigor with practical implementation experience, and which has helped its member organizations across more than twelve African nations collaborate closely together over the years since then today.

Funded through the European Union’s Seventh Framework Programme for research and technological development, the HARP Project operates as part of a wider effort to support collaborative science addressing major global health challenges. The grant framework enables institutions in Africa and Europe to work together on shared priorities, exchanging methodologies, and to build research capacity in partner countries. This international funding structure reflects a recognition that diseases like cervical cancer require coordinated responses that transcend national boundaries, and that meaningful progress depends on sustained partnerships between researchers, healthcare providers, and policy institutions serving communities across many regions throughout the African continent and the wider world today tomorrow soon.

A key dimension of the HARP Project involves examining how HIV status influences HPV-related health outcomes, particularly among women in southern Africa. The research explores the intersections between HIV and HPV infections, recognizing that women living with HIV may face elevated risks for cervical cancer and require tailored screening and prevention approaches. By integrating this focus into the broader partnership, the project aims to develop more nuanced and effective strategies, acknowledging that women’s reproductive health cannot be addressed in isolation from other health conditions, and that integrated care models may offer improved outcomes for vulnerable populations across many different regions and communities throughout sub-Saharan Africa and connected regions today.

Ultimately, the HARP Project seeks to contribute evidence-based insights that can inform policy and practice in cervical cancer prevention across African settings. Through its collaborative structure involving partners in Johannesburg, Ouagadougou, Montpellier, and London, the project combines local knowledge with international expertise. The consortium’s work spans science, prevention, screening, and treatment research, supporting broader development goals and the improvement of women’s health outcomes. By fostering partnerships among diverse institutions and supporting rigorous science, the consortium contributes to ongoing global discussions about effective cancer prevention and the strengthening of healthcare systems serving women throughout the African continent and beyond, across many communities, populations, and nations today.

Contact